Literature DB >> 9415891

Adenoviral preterminal protein stabilizes mini-adenoviral genomes in vitro and in vivo.

A Lieber1, C Y He, M A Kay.   

Abstract

In the absence of host immunity, nonintegrating, first-generation adenoviral vectors remain stable in the nucleus of quiescent transduced cells in mice. A mini-adenoviral genome (9 kb) deleted for viral E1, E2, E3, and late genes, but containing the viral inverted terminal repeats (ITRs), transgene expression cassette (human alpha 1-antitrypsin), and the viral E4 genes was equally efficient at transducing cells in vitro or in vivo as first generation, E1-deleted vectors. In contrast to a first generation vector, gene expression as well as vector DNA was short-lived in cells transduced with the deleted adenoviral genome. We demonstrate that coexpression of the adenoviral E2-preterminal protein from the vector or in trans stabilizes the mini-genome in vitro and in vivo without evidence of cellular toxicity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9415891     DOI: 10.1038/nbt1297-1383

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  8 in total

1.  Generation of adenovirus vectors devoid of all viral genes by recombination between inverted repeats.

Authors:  D S Steinwaerder; C A Carlson; A Lieber
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.

Authors:  A Lieber; D S Steinwaerder; C A Carlson; M A Kay
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

3.  L1 retrotransposition in nondividing and primary human somatic cells.

Authors:  Shuji Kubo; Maria Del Carmen Seleme; Harris S Soifer; José Luis Garcia Perez; John V Moran; Haig H Kazazian; Noriyuki Kasahara
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-12       Impact factor: 11.205

Review 4.  Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

Authors:  Timothy C Nichols; Aaron M Dillow; Helen W G Franck; Elizabeth P Merricks; Robin A Raymer; Dwight A Bellinger; Valder R Arruda; Katherine A High
Journal:  ILAR J       Date:  2009

5.  Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs.

Authors:  N Chirmule; J V Hughes; G P Gao; S E Raper; J M Wilson
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

6.  Episomal persistence of recombinant adenoviral vector genomes during the cell cycle in vivo.

Authors:  Anja Ehrhardt; Hui Xu; Mark A Kay
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

7.  Transient inhibition of CD28 and CD40 ligand interactions prolongs adenovirus-mediated transgene expression in the lung and facilitates expression after secondary vector administration.

Authors:  C B Wilson; L J Embree; D Schowalter; R Albert; A Aruffo; D Hollenbaugh; P Linsley; M A Kay
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

8.  Structural and functional annotation of hypothetical proteins of human adenovirus: prioritizing the novel drug targets.

Authors:  Muhammad Naveed; Sana Tehreem; Muhammad Usman; Zoma Chaudhry; Ghulam Abbas
Journal:  BMC Res Notes       Date:  2017-12-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.